| Literature DB >> 30869558 |
Zachary A Graham1,2, Jacob A Siedlik3, Lauren Harlow1, Karim Sahbani1, William A Bauman1,4,2,5, Hesham A Tawfeek1,2, Christopher P Cardozo1,4,2,5.
Abstract
Spinal cord injury (SCI) results in rapid muscle atrophy and an oxidative-to-glycolytic fiber-type shift. Those with chronic SCI are more at risk for developing insulin resistance and reductions in glucose clearance than able-bodied individuals, but how glucose metabolism is affected after SCI is not well known. An untargeted metabolomics approach was utilized to investigate changes in whole-muscle metabolites at an acute (7-day) and subacute (28-day) time frame after a complete T9 spinal cord transection in 20-week-old female C57BL/6 mice. Two hundred one metabolites were detected in all samples, and 83 had BinBase IDs. A principal components analysis showed the 7-day group as a unique cluster. Further, 36 metabolites were altered after 7- and/or 28-day post-SCI (p values <0.05), with 12 passing further false discovery rate exclusion criteria; of those 12 metabolites, three important glycolytic molecules-glucose and downstream metabolites pyruvic acid and lactic acid-were reduced at 7 days compared to those values in sham and/or 28-day animals. These changes were associated with altered expression of proteins associated with glycolysis, as well as monocarboxylate transporter 4 gene expression. Taken together, our data suggest an acute disruption of skeletal muscle glucose uptake at 7 days post-SCI, which leads to reduced pyruvate and lactate levels. These levels recover by 28 days post-SCI, but a reduction in pyruvate dehydrogenase protein expression at 28 days post-SCI implies disruption in downstream oxidation of glucose.Entities:
Keywords: glycolysis; metabolomics; paralysis; skeletal muscle; spinal cord injury
Year: 2019 PMID: 30869558 PMCID: PMC6727471 DOI: 10.1089/neu.2018.6144
Source DB: PubMed Journal: J Neurotrauma ISSN: 0897-7151 Impact factor: 5.269